Purification and characterization of flavin-containing monooxygenase isoform 3 from rat kidney microsomes

Drug Metabolism and Disposition

Volumn 36, Issue 12, 2008, Pages 2468-2474

  Novick, Rachel M ^a   Elfarra, Adnan A ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYLANILINE MONOOXYGENASE; METHIONINE; METHIONINE SULFOXIDE REDUCTASE; S ALLYLCYSTEINE; SELENOMETHIONINE; THIAMAZOLE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; DRUG OXIDATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME PURIFICATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KIDNEY METABOLISM; KIDNEY MICROSOME; LIVER MICROSOME; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICHAELIS MENTEN KINETICS; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RAT; STEREOCHEMISTRY;

AMINO ACID SEQUENCE; ANIMALS; CATALYSIS; CYSTEINE; KIDNEY; KINETICS; MALE; METHIMAZOLE; METHIONINE; MICROSOMES; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; NADP; OXYGENASES; RATS; RATS, SPRAGUE-DAWLEY; SELENOMETHIONINE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STEREOISOMERISM;

ANIMALIA; RATTUS;

EID: 56649119417     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.108.021436     Document Type: Article

References (40)

1. Borbás T, Benkocombining double acute accent B, Dalmadi B, Szab[acut]o I, and Tihanyi K (2006) Insulin in flavin-containing monooxygenase regulation: flavin-containing monooxygenase and cytochrome P450 activities in experimental diabetes. Eur J Pharm Sci 28:51-58.
2. Bosy-Westphal A, Ruschmeyer M, Czech N, Oehler G, Hinrichsen H, Plauth M, Lotterer E, Fleig W, and Müller MJ (2003) Determinants of hyperhomocysteinemia in patients with chronic liver disease and after orthotopic liver transplantation. Am J Clin Nutr 77:1269-1277.
3. Burnett VL, Lawton MP, and Philpot RM (1994) Cloning and sequencing of flavin-containing monooxygenases FMO3 and FMO4 from rabbit and characterization of FMO3*. J Biol Chem 269:14314-14322.
4. Cashman JR and Zhang J (2006) Human flavin-containing monooxygenases. Annu Rev Pharmacol Toxicol 46:65-100.
5. Dixit A and Roche TE (1984) Spectrophotometric assay of the flavin-containing monooxygenase and changes in its activity in female mouse liver with nutritional and diurnal conditions. Arch Biochem Biophys 233:50-63.
6. Elfarra AA, Duescher RJ, Sausen PJ, O'Hara TM, and Cooley AJ (1994) Methimazole protection of rats against gentamicin-induced nephrotoxicity. Can J Physiol Pharmacol 72:1238-1244.
7. Falls JG, Ryu DY, Cao Y, Levi PE, and Hodgson E (1997) Regulation of mouse liver flavin-containing monooxygenases 1 and 3 by sex steroids. Arch Biochem Biophys 342:212-223.
8. Gahl WA, Bernardini I, Finkelstein JD, Tangerman A, Martin JJ, Blom HJ, Mullen KD, and Mudd SH (1988) Transsulfuration in an adult with hepatic methionine adenosyltransferase deficiency. J Clin Invest 81:390-397.
9. Helen A, Krishnakumar K, Vijayammal PL, and Augusti KT (2003) A comparative study of antioxidants S-allyl cysteine sulfoxide and vitamin E on the damages induced by nicotine in rats. Pharmacology 67:113-117.
10. Hernandez D, Janmohamed A, Chandan P, Phillips IR, and Shepard EA (2004) Organization and evolution of the flavin-containing monooxygenase genes of human and mouse: identification of novel gene and pseudogene clusters. Pharmacogenetics 14:117-130.
11. Hsu CC, Lin CC, Liao TS, and Yin MC (2006) Protective effect of S-allyl cysteine and S-propyl cysteine on acetaminophen-induced hepatotoxicity in mice. Food Chem Toxicol 44:393-397.
12. Katchamart S, Stressor DM, Dehal SS, Kupfer D, and Williams DE (2000) Concurrent flavin-containing monooxygenase down-regulation and cytochrome P-450 induction by dietary indoles in rat: implications for drug-drug interaction. Drug Metab Dispos 28:930-936.
13. 4-induced acute liver injury in rats. Free Radic Res 41:489-497.
14. Korsmeyer KK, Guan S, Yang Z, Falick AM, Ziegler DM, and Cashman JR (1998) N- glycosylation of pig flavin-containing monooxygenase form: I. Determination of the site of protein modification by mass spectrometry. Chem Res Toxicol 11:1145-1153.
15. Koukouritaki SB, Simpson P, Yeung CK, Rettie AE, and Hines RN (2002) Human hepatic flavin-containing monooxygenases 1 (FMO1) and 3 (FMO3) developmental expression. Pediatr Res 51:236-243.
16. Krause RJ, Glocke SC, and Elfarra AA (2002) Sulfoxides as urinary metabolites of S-allyl-L-cysteine in rats: evidence for the involvement of flavin-containing monooxygenases. Drug Metab Dispos 30:1137-1142.
17. Krause RJ, Glocke SC, Sicuri AR, Ripp SL, and Elfarra AA (2006) Oxidative metabolism of seleno-L-methionine to L-methionine selenoxide by flavin-containing monooxygenase. Chem Res Toxicol 19:1643-1649.
18. Krause RJ, Lash LH, and Elfarra AA (2003) Human kidney flavin-containing monooxygenases and their potential roles in cysteine S-conjugate metabolism and nephrotoxicity. J Pharmacol Exp Ther 304:185-191.
19. Krause RJ, Ripp SL, Sausen PJ, Overby LH, Philpot RM, and Elfarra AA (1996) Characterization of the methionine S-oxidase activity of rat liver and kidney microsomes: immunochemical and kinetic evidence for FMO3 being the major catalyst. Arch Biochem Biophys 333:109-116.
20. Lattard V, Buronfosse T, Lachuer J, Longin-Sauvageon C, Moulin C, and Benoit E (2001) Cloning, sequencing, tissue distribution, and heterologous expression of rat flavin-containing monooxygenase 3. Arch Biochem Biophys 391:30-40.
21. Lattard V, Longin-Sauvageon C, and Benoit E (2003) Cloning, sequencing and tissue distribution of rat flavin-containing monooxygenase 4: two different forms are produced by tissue-specific alternative splicing. Mol Pharmacol 63:253-261.
22. Lattard V, Longin-Sauvageon C, Lachuer J, Delatour P, and Benoit E (2002) Cloning, sequencing and tissue-dependent expression of flavin-containing monooxygenase (FMO) 1 and FMO3 in the dog. Drug Metab Dispos 30:119-128.
23. Lawton MP, Cashman JR, Cresteil T, Dolphin CT, Elfarra AA, Hines RN, Hodgson E, Kimura T, Ozols J, Phillips IR, et al. (1994) A nomenclature for the mammalian flavin-containing monooxygenase gene family based on amino acid sequence identity. Arch Biochem Biophys 308:254-257.
24. Rae JM, Johnson MD, Lippman ME, and Flockhart DA (2001) Rifampin is a selective, pleiotropic inducer of drug metabolism genes in human hepatocytes: studies with cDNA and oligonucleotide expression arrays. J Pharmacol Exp Ther 299:849-857.
25. Ripp SL, Itagaki K, Philpot RM, and Elfarra AA (1999a) Methionine S-oxidation in human and rabbit liver microsomes: evidence for a high affinity methionine S-oxidase activity that is distinct from flavin containing monooxygenase 3. Arch Biochem Biophys 367:322-332.
26. Ripp SL, Itagaki K, Philpot RM, and Elfarra AA (1999b) Species and sex differences in expression of flavin-containing monooxygenase form 3 in liver and kidney microsomes. Drug Metab Dispos 27:46-52.
27. Ripp SL, Overby LH, Philpot RM, and Elfarra AA (1997) Oxidation of cysteine S-conjugates by rabbit liver microsomes and cDNA-expressed flavin-containing monooxygenases: studies with S-(1,2-dichlorovinyl)- L-cysteine, S-(1,2,2-trichlorovinyl)-L-cysteine, S-allyl-L-cysteine, and Sbenzyl-L-cysteine. Mol Pharmacol 51:507-515.
28. Sadeque AJ, Thummel KE, and Rettie AE (1993) Purification of macaque liver flavin-containing monooxygenase: a form of the enzymes related immunochemically to an isozyme expressed selectively in adult human liver. Biochim Biophys Acta 1162:127-134.
29. Sangeetha T and DarlinQuine S (2006) Preventive effect of S-allyl cysteine sulfoxide (allin) on cardiac marker enzymes and lipids in isoproterenol-induced myocardial injury. J Pharm Pharmacol 58:617-623.
30. Sausen PJ, Duescher RJ, and Elfarra AA (1993) Further characterization and purification of the flavin-dependent S-benzyl-L-cysteine S-oxidase activities of rat liver and kidney microsomes. Mol Pharmacol 43:388-396.
31. Sausen PJ and Elfarra AA (1990) Cysteine conjugate S-oxidase: characterization of a novel enzymatic activity in rat hepatic and renal microsomes. J Biol Chem 265:6139-6145.
32. Sausen PJ, Elfarra AA, and Cooley AJ (1991) Methimazole protection of rats against chemically induced kidney damage in vivo. J Pharmacol Exp Ther 260:393-401.
33. Shehin-Johnson SE, Palmer KC, and Hines RN (1996) Identification of a tissue-specific DNase I hypersensitive sites in the rabbit flavin-containing monooxygenase form 2 gene. Drug Metab Dispos 24:891-898.
34. Shepard EA, Chandan P, Stevanovic-Walker M, Edwards M, and Phillips IR (2007) Alternative promoters and repetitive DNA elements define the species-dependent tissue-specific expression of the FMO1 genes of humans and mouse. Biochem J 406:491-499.
35. Tangerman A, Wilcken B, Levy HL, Boers GH, and Mudd HS (2000) Methionine transamination in patients with homocystinuria due to cystathionine β-synthase deficiency. Metabolism 49:1071-1077.
36. Tashjian DH, Teh SJ, Sogomonyan A, and Hung SS (2006) Bioaccumulation and chronic toxicity of dietary L-selenomethionine in juvenile white sturgeon. Aquat Toxicol 79:401-409.
37. Tijet N, Boutros PC, Moffat ID, Okey AB, Tuomisto J, and Pohjanvirta R (2006) Aryl hydrocarbon receptor regulates distinct dioxin-dependent and dioxin-independent gene batteries. Mol Pharmacol 69:140-153.
38. Venkatesh K, Levi PE, and Hodgson E (1991) The flavin-containing monooxygenase of mouse kidney. Biochem Pharmacol 42:1411-1420.
39. Yan SL and Yin MC (2007) Protective and alleviative effects from 4 cysteine-containing compounds on ethanol-induced acute liver injury through suppression of oxidation and inflammation. J Food Sci 72:S511-S515.
40. Yeung CK, Lang DH, Thummel KE, and Rettie AE (2000) Immunoquantitation of FMO1 in human, liver, kidney, and intestine. Drug Metab Dispos 28:1107-1111.